TSPO was widely expressed by numerous tumor-associated HLA-DR+ (human leukocyte antigen D-associated) and Iba-1+ (microglia/macrophages) myeloid cells in a high-grade glioma patient and to a lesser extent in a low-grade glioma patient. The gene discussed is TSPO; the disease is central nervous system cancer.